| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2015 | A review of the burden of hepatitis C virus infection in China, Japan, South Korea, and Taiwan | Bennett, H; Waser, N; Johnston, K; Kao, JH; Lim, YS; Duan, ZP; Lee, YJ; Wei, L; Chen, CJ; Sievert, W; Yuan, Y; Li, H | Hepatol Int 9, 378-390 | | | |
| 2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin, SK; Kumar, M; Lau, GK; Abbas, Z; Chan, HLY; Chen, CJ; Chen, DS; Chen, HL; Chen, PJ; Chien, RN; Dokmeci, AK; Gane, Ed; Hou, JL; Jafri, W; Jia, J; Kim, JH; Lai, CL; Lee, HC; Lim, SG; Liu, CJ; Locarnini, S; Mahtab, M Al; Mohamed, R; Omata, M; Park, J; Piratvisuth, T; Sharma, BC; Sollano, J; Wang, FS; Wei, L; Yuen, MF; Zheng, SS; Kao, JH | Hepatol Int 10(1), 1-98 | | | |
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee, MH; Huang, CF; Lai, HC; Lin, CY; Dai, CY; Liu, CJ; Wang, JH; Huang, JF; Su, WP; Yang, HC; Kee, KM; Yeh, ML; Chuang, PH; Hsu, SJ; Huang, CI; Kao, JT; Chen, CC; Chen, SH; Jeng, WJ; Yang, HI; Yuan, Y; Lu, SN; Sheen, IS; Liu, CH; Peng, CY; Kao, JH; Yu, ML; Chuang, WL; Chen, CJ | Scientific reports 7, 3718 | | | |
| 2019 | Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. | Huang, CF; Iio, E; Jun, DW; Ogawa, E; Toyoda, H; Hsu, YC; Haga, H; Iwane, S; Enomoto, M; Lee, DH; Wong, G; Liu, CH; Tada, T; Chuang, WL; Cheung, R; Hayashi, J; Tseng, CH; Yasuda, S; Tran, S; Kam, L; Henry, L; Jeong, JY; Nomura, H; Park, SH; Nakamuta, M; Huang, JF; Tai, CM; Lo, GH; Lee, MH; Yang, HI ; Kao, JH; Tamori, A; Eguchi, Y; Ueno, Y; Furusyo, N; Tanaka, Y; Yu, ML; Nguyen, MH | Hepatology international 13, 587-598 | | | |
| 2019 | Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. | Yeo, YH; Ho, HJ; Yang, HI ; Tseng, TC; Hosaka, T; Trinh, HN; Kwak, MS; Park, YM; Fung, JYY; Buti, M; Rodriguez, M; Treeprasertsuk, S; Preda, CM; Ungtrakul, T; Charatcharoenwitthaya, P; Li, X; Li, J; Zhang, J; Le, MH; Wei, B; Zou, B; Le, A; Jeong, D; Chien, N; Kam, L; Lee, CC; Riveiro-Barciela, M; Istratescu, D; Sriprayoon, T; Chong, Y; Tanwandee, T; Kobayashi, M; Suzuki, F; Yuen, MF; Lee, HS; Kao, JH; Lok, AS; Wu, CY; Nguyen, MH | Gastroenterology 156(3), 635-646.e9 | | | |
| 2019 | HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. | Ogawa, E; Toyoda, H; Iio, E; Jun, DW; Huang, CF; Enomoto, M; Hsu, YC; Haga, H; Iwane, S; Wong, G; Lee, DH; Tada, T; Liu, CH; Chuang, WL; Hayashi, J; Cheung, R; Yasuda, S; Tseng, CH; Takahashi, H; Tran, S; Yeo, YH; Henry, L; Barnett, SD; Nomura, H; Nakamuta, M; Dai, CY; Huang, JF; Yang, HI ; Lee, MH; Jung Jun, M; Kao, JH; Eguchi, Y; Ueno, Y; Tamori, A; Furusyo, N; Yu, ML; Tanaka, Y; Nguyen, MH; Ahn, SB; Azuma, K; Dohmen, K; Yoon Jeong, J; Jung, JH; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Ooho, A; Park, SH; Satoh, T; Shimoda, S; Song, DS; Takahashi, K; Yeh, ML; Yoon, EL | Clinical Infectious Diseases, ciz1160 | | | |
| 2023 | Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries | Razavi, HA; Buti, M; Terrault, NA; Zeuzem, S; Yurdaydin, C; Tanaka, J; Aghemo, A; Akarca, US; Al Masri, NM; Alalwan, AM; Aleman, S; Alghamdi, AS; Alghamdi, S; Al-Hamoudi, WK; Aljumah, AA; Altraif, IH; Asselah, T; Ben-Ari, Z; Berg, T; Biondi, MJ; Blach, S; Braga, WSM; Brandao-Mello, CE; Brunetto, MR; Cabezas, J; Cheinquer, H; Chen, PJ; Cheon, ME; Chuang, WL; Coffin, CS; Coppola, N; Craxi, A; Crespo, J; De Ledinghen, V; Duberg, AS; Etzion, O; Ferraz, MLG; Ferreira, PRA; Forns, X; Foster, GR; Gaeta, GB; Gamkrelidze, I; Garcia-Samaniego, J; Gheorghe, LS; Gholam, PM; Gish, RG; Glenn, J; Hercun, J; Hsu, YC; Hu, CC; Huang, JF; Janjua, N; Jia, J; Kaberg, M; Kaita, KDE; Kamal, H; Kao, JH; Kondili, LA; Lagging, M; Lazaro, P; Lazarus, JV; Lee, MH; Lim, YS; Marotta, PJ; Navas, MC; Naveira, MCM; Orrego, M; Osiowy, C; Pan, CQ; Pessoa, MG; Raimondo, G; Ramji, A; Razavi-Shearer, DM; Razavi-Shearer, K; Rios-Hincapie, CY; Rodriguez, M; Rosenberg, WMC; Roulot, DM; Ryder, SD; Safadi, R; Sanai, FM; Santantonio, TA; Sarrazin, C; Shouval, D; Tacke, F; Tergast, TL; Villalobos-Salcedo, JM; Voeller, AS; Yang, HI ; Yu, ML; Zuckerman, E | JOURNAL OF HEPATOLOGY 79(2), 576-580 | | | |
| 2013 | Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients | Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH | PLoS One 8:e53008 | | | |
| 2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang, HI ; Tseng, TC; Liu, J; Lee, MH; Liu, CJ; Su, TH; Batrla-Utermann, R; Chan, HL; Kao, JH; Chen, CJ | Clinical gastroenterology and hepatology 14(3), 461-468.e2 | | | |
| 2015 | Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System | Liu, J; Tseng, TC; Yang, HI; Lee, MH; Batrla-Utermann, R; Jen, CL; Lu, SN; Wang, LY; You, SL; Chen, PJ; Chen, CJ; Kao, JH | The Journal of infectious diseases 211(10), 1566-1573 | | | |
| 2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2015 | Slow decline of hepatitis B burden in general population:results from a population-based survey and longitudinal follow-up study in Taiwan | Chen, CL; Yang, JY; Lin, SF; Sun, CA; Bai, CH; You, SL; Chen, CJ; Kao, JH; Chen, PJ; Chen, DS | J Hepatol | | | |
| 2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 | | | |
